Veterinary Medicines

Bupaq Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats

Authorised
  • Buprenorphine hydrochloride
Download as PDF

Product identification

Medicine name:
Bupaq Multidose 0,3mg/ml Injektionslösung für Hunde und Katzen
Bupaq Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats
Active substance:
  • Buprenorphine hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Buprenorphine hydrochloride
    0.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AE01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Amber glass vials type I, bromobutyl rubber stopper type I, coated, aluminium cap Package size: 10 ml
  • Amber glass vials type I, bromobutyl rubber stopper type I, coated, aluminium cap Package size: 10 x 10 ml
  • Amber glass vials type I, bromobutyl rubber stopper type I, coated, aluminium cap Package size: 5 x 10 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetviva Richter GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA23462/003/001
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0008/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."